Event report: VOXPO 2020
The ACI are education partners for the upcoming Virtual Online Vape and CBD Expo – Voxpo. The event runs from 31 July until 2 August.
[The Grocer] CBD will be removed from shelves next year, are you prepared?
The UK is the only market in the world where a clear regulatory framework exists for commercial adoption of CBD giving retailers the opportunity to participate in this huge market. However, they must ensure that their procurement process is able to identify the products that are fully safe and legal.
[Natural Products Global] ACI Launches CBD Safety Study Consortium as Novel Food Deadline Looms
UK trade body the Association for the Cannabinoid Industry (The ACI) will lead a new CBD safety study consortium to generate data to assess the safety of CBD and evaluate dosage impacts.
[CBD Intel] Researchers on safety and toxicity confident of hitting UK deadlines
An industry association study of the safety and toxicity of cannabinoids is expected to be completed in time to meet submission deadlines to keep CBD-containing food, beverage and supplement products on the UK market.
[Food Navigator] CBD body announces safety study consortium as Novel Foods crunch time looms
Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK, says it will lead a consortium to study the safety of CBD and decide the ingredient’s recommended daily dose.
The ACI Responds to Global Regulatory Calls for Evidence of CBD Safety by Launching Study Consortium
The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.
ACI Bolsters Regulatory and Compliance Unit To Support UK CBD Industry
The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.
[Nutra Ingredients] FSA provides clarity to ACI members’ CBD Novel Foods Queries.
The ACI have received clarification from the Food Standards Agency regarding updated deadlines set for Cannabinoid firms to apply for Novel Foods.
[Health Europa] FSA provides clarification concerning CBD Novel Foods applications
The FSA clarified that several products may fall within the scope of a single CBD Novel Foods application, meaning that the finished product must be made with the applied for substance, for example, a CBD extract made by ‘X’ manufacturer, and that ‘the end use or presentation of the finished products is within the ‘uses’ identified by the application’, such as 5% CBD extract in oil.
[New Food Magazine] FSA clarifies CBD novel food application questions
Members from the Association for the Cannabinoid Industry (ACI) recently raised questions regarding CBD novel food dossier applications in the UK, and the FSA has now responded to their questions in a Q&A.
